Cystic Fibrosis Newswire (Page 6)

Cystic Fibrosis Newswire (Page 6)

Comprehensive Real-Time News Feed for Cystic Fibrosis. (Page 6)

Results 101 - 120 of 1,065 in Cystic Fibrosis

  1. Townsend Award winner Bourque makes town a better placeRead the original story w/Photo

    Sep 28, 2017 | The Wakefield Daily Item

    ... Day to the highly anticipated spring event. Additionally, Price said Bourque is actively involved with the Cystic Fibrosis Foundation, where he served on the board of directors for nearly two decades. She said he is involved with the Reid R. Sacco ...

    Comment?

  2. Alcobra, Arcturus Therapeutics Merge Into $40 Million Biotech to Bring Drugs Into ClinicRead the original story

    Sep 27, 2017 | BioSpace

    ... company focused on developing novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases. Arcturus has developed proprietary technology platforms incorporating ...

    Comment?

  3. Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to MergeRead the original story

    Sep 27, 2017 | Customer Interaction Solutions

    ... company focused on developing novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases. Arcturus has developed proprietary technology platforms incorporating ...

    Comment?

  4. AzurRx BioPharma And Mayoly Spindler Announce Positive MS1819-SD...Read the original story

    Sep 26, 2017 | BioSpace

    ... for the treatment of exocrine pancreatic insufficiency (EPI) associated with chronic pancreatitis (CP) and cystic fibrosis (CF). Early Phase Ib data in EPI patients treated with MS1819 showed a favorable safety profile and encouraging preliminary ...

    Comment?

  5. Cole, Vaughn R.Read the original story w/Photo

    Sep 26, 2017 | The Marion Star

    ... take place in the Glendale Cemetery. Those wishing to make a memorial contribution are asked to consider the Cystic Fibrosis Foundation. Those wishing to share a memory of Vaughn or to express a condolence to the Cole family may do so by visiting ...

    Comment?

  6. ProQR Therapeutics Jumps as CF Drug Impresses in Early Stage TrialRead the original story

    Sep 25, 2017 | BioSpace

    ... at baseline a mean absolute change in ppFEV1 was observed up to 10.9% compared to placebo. ProQR and the Cystic Fibrosis Foundation Therapeutics intend to expand their partnership to explore the inhaled oligonucleotide platform to target stop-codon ...

    Comment?

  7. Sound Pharmaceuticals, Inc. Initiates STOP Ototoxicity Study In Cystic FibrosisRead the original story

    Sep 25, 2017 | BioSpace

    ... Pharmaceuticals (SPI) is pleased to announce that it has initiated enrollment on its first study involving Cystic Fibrosis (CF) patients receiving antibiotics that cause inner ear disease or ototoxicity. The STOP Ototoxicity study is led by Patrick ...

    Comment?

  8. ProQR Announces Positive Top-Line Results from a Phase 1b Study of...Read the original story

    Sep 25, 2017 | Customer Interaction Solutions

    ... at baseline a mean absolute change in ppFEV1 was observed up to 10.9% compared to placebo. ProQR and the Cystic Fibrosis Foundation Therapeutics intend to expand their partnership to explore the inhaled oligonucleotide platform to target stop-codon ...

    Comment?

  9. Sound Pharmaceuticals initiates STOP Ototoxicity Study in Cystic FibrosisRead the original story w/Photo

    Sep 25, 2017 | PR Newswire

    ... Pharmaceuticals (SPI) is pleased to announce that it has initiated enrollment on its first study involving Cystic Fibrosis (CF) patients receiving antibiotics that cause inner ear disease or ototoxicity. The STOP Ototoxicity study is led by Patrick ...

    Comment?

  10. Team Nathan fundraiser brings in $2K for cystic fibrosis -Read the original story w/Photo

    Sep 25, 2017 | Bladen Journal

    "We're just living on a prayer that they find a cure before it's too late," said Tesla Nance, step-mother to 15-year-old Nathan. Nathan has cystic fibrosis, a genetic disease affecting 30,000 people in the United State and 70,000 worldwide.

    Comment?

  11. 3 Monster Biotech Stocks in the MakingRead the original story w/Photo

    Sep 24, 2017 | The Motley Fool

    ... Vertex reported its first profit in the fourth quarter of 2016 on the back of strong sales growth of its two cystic fibrosis drugs, Kalydeco and Orkambi (which is a combination of Kalydeco and another of Vertex's drugs, lumacaftor). The biotech has ...

    Comment?

  12. How a Double Lung Transplant Saved the Life of a New MomRead the original story w/Photo

    Sep 22, 2017 | Newswise

    Newswise - MAYWOOD, IL Cystic fibrosis patient Fanny Vlahos was nearing the end of the second trimester of her pregnancy when she caught pneumonia and her lung function declined drastically. By the time her son was four months old, Mrs. Vlahos was tethered to an oxygen tank and too weak to even bend over the crib and pick him up.

    Comment?

  13. Take That, Jimmy KimmelRead the original story w/Photo

    Sep 22, 2017 | The New York Times

    ... with the American Cancer Society Cancer Action Network, the American Diabetes and Lung associations, the Cystic Fibrosis Foundation, the March of Dimes and others. It would hurt "consumers and patients by further destabilizing the individual market; ...

    Comment?

  14. UVic student loses coverage for pricey cystic fibrosis drugRead the original story w/Photo

    Sep 22, 2017 | CBC News

    ... at the University of Victoria says she was put on the drug Orkambi - which targets the underlying causes of cystic fibrosis caused by a specific gene mutation - not just the symptoms. Her quality of life dramatically improved. But Orkambi is ...

    Comment?

  15. 4D Molecular Therapeutics Receives $3 Million Follow-On Funding From...Read the original story

    Sep 18, 2017 | BioSpace

    ... gene therapy vector discovery and product development, today announced $3 million in additional funding from Cystic Fibrosis Foundation Therapeutics Inc., (CFFT) the non-profit drug discovery and development affiliate of the Cystic Fibrosis (CF) ...

    Comment?

  16. Pulmatrix: The Best Biotech Buyout Target Out There?Read the original story w/Photo

    Jan 17, 2017 | Seeking Alpha

    ... minimizing side effects. PUR1900 is the first inhaled anti-fungal product candidate for severe asthma and Cystic Fibrosis. PUR1900 is in Phase 1 of development. PUR1900 has Qualified Infectious Disease Product (QIDP) designation from the FDA, Orphan ...

    Comment?

  17. BBQ, pumpkin spice, chili and wine: Fall in Wichita full of food festsRead the original story w/Photo

    Sep 16, 2017 | The Wichita Eagle

    ... 7 p.m. Sept. 28, Century II Exhibition Hall Balcony, 225 W. Douglas: This party, which raises money for the Cystic Fibrosis Foundation, is in its eighth year and will have food from several Wichita restaurants plus wine-tasting stations. It usually ...

    Comment?

  18. Cystic fibrosis sufferers put their hope in a change of GovernmentRead the original story w/Photo

    Sep 16, 2017 | Stuff.co.nz

    Parents of child with Cystic Fibrosis have been fighting for Pharmac to make a revolutionary but very expensive drug available in NZ. The parents of a 12-year-old boy who suffers from cystic fibrosis say a Labour victory is their only hope of getting life-changing drugs for their son.

    Comment?

  19. Cystic fibrosis alters the structure of mucus in airwaysRead the original story w/Photo

    Jun 30, 2017 | Medical News Today

    ... projections on the surface of the airway cells - sweep the mucus out of the airway. In lungs affected by cystic fibrosis (CF), the mucus is abnormal and the lung-clearing process breaks down. This deficit may contribute to lung infections and ...

    Comment?

  20. Potential new treatment for cystic fibrosis uncoveredRead the original story w/Photo

    Apr 10, 2017 | Medical News Today

    Cystic fibrosis is an inherited disease that affects tens of thousands of people in the United States and worldwide. There is currently no cure for the condition, but new research proposes a novel therapeutic approach that may soon stop the disease from progressing.

    Comment?